Relevant bibliographies by topics / TARS2

Contents

  1. Journal articles
  2. Dissertations / Theses
  3. Books
  4. Book chapters
  5. Conference papers
  6. Reports

Academic literature on the topic 'TARS2'

Author: Grafiati
Published: 9 March 2023
Last updated: 10 March 2023

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the lists of relevant articles, books, theses, conference reports, and other scholarly sources on the topic 'TARS2.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Journal articles on the topic "TARS2"

1

Zhou, Xiao-Long, Yun Chen, Qi-Yu Zeng, Zhi-Rong Ruan, Pengfei Fang, and En-Duo Wang. "Newly acquired N-terminal extension targets threonyl-tRNA synthetase-like protein into the multiple tRNA synthetase complex." Nucleic Acids Research 47, no. 16 (July 9, 2019): 8662–74. http://dx.doi.org/10.1093/nar/gkz588.

Full text
Abstract:
Abstract A typical feature of eukaryotic aminoacyl-tRNA synthetases (aaRSs) is the evolutionary gain of domains at either the N- or C-terminus, which frequently mediating protein–protein interaction. TARSL2 (mouse Tarsl2), encoding a threonyl-tRNA synthetase-like protein (ThrRS-L), is a recently identified aaRS-duplicated gene in higher eukaryotes, with canonical functions in vitro, which exhibits a different N-terminal extension (N-extension) from TARS (encoding ThrRS). We found the first half of the N-extension of human ThrRS-L (hThrRS-L) is homologous to that of human arginyl-tRNA synthetase. Using the N-extension as a probe in a yeast two-hybrid screening, AIMP1/p43 was identified as an interactor with hThrRS-L. We showed that ThrRS-L is a novel component of the mammalian multiple tRNA synthetase complex (MSC), and is reliant on two leucine zippers in the N-extension for MSC-incorporation in humans, and mouse cell lines and muscle tissue. The N-extension was sufficient to target a foreign protein into the MSC. The results from a Tarsl2-deleted cell line showed that it does not mediate MSC integrity. The effect of phosphorylation at various sites of hThrRS-L on its MSC-targeting is also explored. In summary, we revealed that ThrRS-L is a bona fide component of the MSC, which is mediated by a newly evolved N-extension domain.
APA, Harvard, Vancouver, ISO, and other styles
2

Schlichting, J. E. P. T. "Tarsp." Taalverwerving in onderzoek 30 (January 1, 1988): 81–92. http://dx.doi.org/10.1075/ttwia.30.08ver.

Full text
Abstract:
In this article a preliminary report is given of a research project concerning a Dutch version of Crystal, Fletcher & Garman's LARSP, Language Assessment Remediation and Screening Procedure, a gram-matical developmental scale for the use of language therapy. The first Part of the project consisted of a longitudinal study of 15 children between 1;3 and 3;6 with six monthly spontaneous language samples per child. The result of this study showed that the most striking and stable characteristic of grammatical development till the age of four was the increasing number of constituents in the sentence (with the Declarative sentence having one more constituent than the Command and the Question in all stages, compare Wells, 1985). Based on this a cross-sectional study was carried out with the number of constituents of the Declarative or the same number minus one in and Q as a language measure. After assigning the 100 children involved to the seven stages of the Dutch TARSP, the lower language level part of the scale was constructed: Wordgroups, Connectives, Pronouns and Word Structure. The Dutch version of TARSP is compared to a smal-ler Dutch study based on LARSP with a different methodological set-up: GRAMAT.
APA, Harvard, Vancouver, ISO, and other styles
3

Dufour, Michel. "Tarse antérieur." Kinésithérapie, la Revue 15, no. 164-165 (August 2015): 20–22. http://dx.doi.org/10.1016/j.kine.2015.05.007.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Dodd, W. Alan. "Tars." Dermatologic Clinics 11, no. 1 (January 1993): 131–35. http://dx.doi.org/10.1016/s0733-8635(18)30289-4.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Han, Yu, and Yunsi Fei. "TARS." ACM Transactions on Sensor Networks 13, no. 4 (December 4, 2017): 1–25. http://dx.doi.org/10.1145/3105149.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Park, Chul-Hyun. "Prevalence of AALTF and relevant associated MR findings in persons with and without sinus tarsi pain." Foot & Ankle Orthopaedics 3, no. 3 (July 1, 2018): 2473011418S0037. http://dx.doi.org/10.1177/2473011418s00377.

Full text
Abstract:
Category: Ankle Introduction/Purpose: Sinus tarsi pain is very common, however, etiology of this condition has not been well understood. The purpose of this study was to evaluate differences of MRI findings between persons with and without sinus tarsi pain and to investigate the relationships of sinus tarsi pain and accessory anterolateral talar facet (AALTF). Methods: We reviewed MR images of 120 ankles with sinus tarsi pain in 115 consecutively registered patients. And age- and sex-matched MR images of 120 ankles without pain were also reviewed. We compared the presence of AALTF, calcaneal cyst (CC), bone marrow edema (BME), sinus tarsi fat obliteration (STFO) at the Gissane angle, and coalition between persons with and without sinus tarsi pain. We also compared Gissane angle, talar infero-lateral surface angle (TILSA), and calcaneal cortical thickness (CCT). Of persons with sinus tarsi pain, we compared these parameters between persons with and without AALTF. Results: AALTF was present in 61 ankles (50.8%) with sinus tarsi pain and 34 ankles (28.3%) without sinus tarsi pain (P<0.001). BME (P=0.001) and STFO (P=0.009) were significantly more frequent in persons with sinus tarsi pain. Presences of CC (P=0.108) and coalition (P=0.605) were not different. The Gissane angle was significantly smaller in persons with sinus tarsi pain than in persons without sinus tarsi pain (P<0.001) and TILSA (P=0.032), and CCT (P<0.001) were significantly larger in persons without sinus tarsi pain (Table 1). Of persons with sinus tarsi pain, BME was significantly more frequent in persons with AALTF and TILSA (P=0.032) and CCT were significantly larger in persons with AALTF (Table 2). Conclusion: The MRI findings of patients with sinus tarsi pain showed higher prevalence of AALTF, BME, and STFO. The AALTF may be associated with the MRI findings of talar and calcaneal BME.
APA, Harvard, Vancouver, ISO, and other styles
7

Akiyama, Koichi, Yoshinori Takakura, Yasuharu Tomita, Kazuya Sugimoto, Yasuhito Tanaka, and Susumu Tamai. "Neurohistology of the sinus tarsi and sinus tarsi syndrome." Journal of Orthopaedic Science 4, no. 4 (July 1999): 299–303. http://dx.doi.org/10.1007/s007760050107.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Beltran, Javier. "SINUS TARSI SYNDROME." Magnetic Resonance Imaging Clinics of North America 2, no. 1 (February 1994): 59–65. http://dx.doi.org/10.1016/s1064-9689(21)00325-1.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Dellon, A. Lee, and Stephen L. Barrett. "Sinus Tarsi Denervation." Journal of the American Podiatric Medical Association 95, no. 2 (March 1, 2005): 108–13. http://dx.doi.org/10.7547/0950108.

Full text
Abstract:
Traumatic neuroma of the branches of the deep peroneal nerve that innervate the sinus tarsi can be the source of recalcitrant lateral ankle pain. That these nerves can be the source of the pain can be demonstrated by nerve blocks, and this pain can be surgically treated by resection of the appropriate branch of the deep peroneal nerve. This article documents the clinical results of this approach in 13 patients with sinus tarsi syndrome. At a minimum of 6 months postoperatively, 10 patients (77%) were completely pain-free, wore normal shoes, and had returned to work. Two patients (15%) had a small degree of residual pain but resumed usual activities and wore normal footwear. One patient had some pain relief but could not resume usual activities. We conclude that denervation of the sinus tarsi can relieve recalcitrant pain emanating from the sinus tarsi. This approach may reduce the need for subtalar fusion or evacuation procedures, including arthroereisis, thus avoiding their potential complications. Moreover, sinus tarsi denervation may allow the continued use of an arthroereisis implant in the presence of satisfactory objective findings, despite the subjective presence of postoperative pain. (J Am Podiatr Med Assoc 95(2): 108–113, 2005)
APA, Harvard, Vancouver, ISO, and other styles
10

Crawford, Michael. "Sinus Tarsi Artery." Journal of Foot and Ankle Surgery 50, no. 6 (November 2011): 786. http://dx.doi.org/10.1053/j.jfas.2011.09.013.

Full text
APA, Harvard, Vancouver, ISO, and other styles
More sources

Dissertations / Theses on the topic "TARS2"

1

DIODATO, DARIA. "Identification and functional validation of new mtDNA and nuclear gene variants responsible for mitochondrial disorders." Doctoral thesis, Università degli Studi di Milano-Bicocca, 2014. http://hdl.handle.net/10281/50549.

Full text
Abstract:
My project has been focused on the identification and validation of new mitochondrial gene variants and new mitochondria-related genes. The first report is about a woman presenting with a stroke-like episode and an history of severe hearing loss, frequent migraines, exercise intolerance, myalgias and limb-girdle muscle weakness indicating a slowly progressive myopathy and secondary amenorrhea with low gonadotropin levels. A muscle biopsy showed ragged-red, cytochrome c oxidase-negative fibers, and an isolated defect of cytochrome c oxidase activity in muscle mitochondria and sequence analysis of muscle mtDNA revealed a new heteroplasmic m.6597C>A transversion in the MTCOI gene, encoding subunit I of cytochrome c oxidase. Analysis on transmitochondrial cybrids demonstrated that the mutation is indeed associated with COX deficiency, i.e. pathogenic. The second report is about a new phenotype associated to mutations in the AARS2 gene encoding for the mitochondrial aminoacyl tRNA synthetase, identified in six patients presenting with primary ovarian failure, cerebellar and pyramidal signs and cognitive or behavioural disturbances. Two patients underlined a muscle biopsy which showed a severe complex IV defect at histochemical and biochemical analyses. The third report is about the clinical and biochemical phenotypes associated with mutations in two new mitochondrial aminoacyl tRNA synthetases (ARSs2) genes. In the first patient, an 8 years old child presenting with psychomotor delay, seizures, facial dysmorphisms and hyperlactacidemia and a brain MRI showing hyperintense lesions in the insula and fronto-temporal right cortex, whole exome sequencing (WES) identified a homozygous missense mutation in VARS2, encoding the mitochondrial valyl tRNA-synthetase. In two siblings presenting with a phenotype characterized by hypotonia and psychomotor retardation, high plasma and liquor lactate, both died at few months of age WES revealed two variants in TARS2, encoding the mitochondrial threonyl tRNA-synthetase: a missense and a splice site mutation. VARS2 and TARS2 mutations segregate within patients families. Patients’ clinical- biochemical phenotype and in silico and in vitro analyses of VARS2 and TARS2 mutations clearly indicate these genes as disease-causative. Expression of the corresponding wild-type enzymes led to recovery of the biochemical impairment of mitochondrial respiration in immortalized mutant fibroblasts; yeast modelling of the VARS2 mutation confirmed its pathogenic role.
APA, Harvard, Vancouver, ISO, and other styles
2

Romero, Jean-François. "Actualités sur les synostoses tarsiennes en 1989 : à propos de 14 cas." Montpellier 1, 1990. http://www.theses.fr/1990MON11017.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Stiles, Hugh Ninian. "Secondary reactions of pyrolytic tars." Thesis, Imperial College London, 1987. http://hdl.handle.net/10044/1/46671.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Kim, Young. "The Effects of Tarsh Overexpression on Lung Carcinomas." VCU Scholars Compass, 2013. http://scholarscompass.vcu.edu/etd/498.

Full text
Abstract:
Lung cancer arises from epithelial cells that line the air passages of the lungs. It is the second most common malignancy in the United States; trends suggest that over 228,000 new patients will be diagnosed with lung cancer in 2013. Due to the fact that lung cancer is highly aggressive, it has proven difficult to control. The 5-year survival rate has been shown to be only 15.9%, despite the advances made in terms of diagnosis and treatment. Therefore, we are faced with the problem of finding more effective methods that allow for an earlier diagnosis and the improved treatment of lung cancer. This study attempts to address these issues by investigating Tarsh, a novel molecule that is involved in the regulation of cellular senescence. Previous studies have shown that Tarsh is expressed in normal lung cells, but is significantly downregulated in lung tumors. These studies also determined that Tarsh is likely dependent upon the expression of p53, a tumor suppressor gene. The current study investigated these results, in addition to the biological effects of ectopically increasing Tarsh and/or knocking down p53 expression in two lung cancer cell lines: A549 and H1299 cell lines. It was determined that increasing the expression of Tarsh decreased the rate of proliferation in both cell lines. Additionally, it was shown that the knockdown of p53 increased proliferation in A549 cells. In regards to the migration rate of these cell lines, the overexpression of Tarsh decreased migration in A549 cells, but had no effect on H1299 cells. However, the role of p53 in migration is still unclear. The results of this study suggest that the knockdown of p53 decreases cell migration in A549 cells. This contradicts the fact that H1299 cells do not express p53, yet was found to have the highest migration rate. It is evident that a further investigation is needed to make more concrete conclusions. Nevertheless, the suppressive features of Tarsh on cell proliferation, and possibly migration, make it a promising target of research for lung cancer therapy.
APA, Harvard, Vancouver, ISO, and other styles
5

DUVERGNE, PHILIPPE. "L'osteolyse idiopathique a debut carpo-tarsien : a propos d'une observation personnelle avec revue de la litterature." Lyon 1, 1989. http://www.theses.fr/1989LYO1M354.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

COICAUD, CHRISTIAN. "La greffe tarso-marginale : sa place en chirurgie reconstructive palpebrale." Reims, 1994. http://www.theses.fr/1994REIMM039.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

WAKOH, TAKESHI, MASATAKA SUGIMOTO, KUNIHIKO TERAUCHI, JUN-ICHI SHIMADA, and MITSUO MARUYAMA. "A NOVEL P53-DEPENDENT APOPTOSIS FUNCTION OF TARSH IN TUMOR DEVELOPMENT." Nagoya University School of Medicine, 2009. http://hdl.handle.net/2237/12347.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

MICHAULT, ERIC. "Savoir evoquer une synostose tarsienne devant un pied pathologique de l'enfant : etude faite a partir de 547 observations." Lyon 1, 1988. http://www.theses.fr/1988LYO1M178.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Boroson, Michael L. (Michael Louis). "Secondary reactions of tars from pyrolysis of sweet gum hardwood." Thesis, Massachusetts Institute of Technology, 1987. http://hdl.handle.net/1721.1/14859.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Hauser, Michael [Verfasser]. "Effects of Tars on Solid Oxide Fuel Cells / Michael Hauser." München : Verlag Dr. Hut, 2021. http://d-nb.info/1235279243/34.

Full text
APA, Harvard, Vancouver, ISO, and other styles
More sources

Books on the topic "TARS2"

1

Patel, Govindbhai. Tarsi sanj. Bombay: Navbharat, 1991.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
2

Dukhtar-i tarsā. Sūʼid: Nashr-i Bārān, 2011.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
3

Dukhtar-i tarsā. Sūʼid: Nashr-i Bārān, 2011.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
4

Hubaut, Michel. Paul de Tarse. Paris: Desclée, 1989.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
5

Jacques, Schlosser, ed. Paul de Tarse. Paris: Cerf, 1996.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
6

Bantaivala, Amrut. Tarsi dhara tarsyan manvi. Ahmedabad: Kothari, 1992.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
7

Torbado, Jesús. Yo, Pablo de Tarso. Barcelona, España: Planeta, 1990.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
8

Arnaldos, Manuel. El peregrino de Tarso. Molina de Segura, Murcia: Escuela de Jo venes Cristianos, 1995.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
9

Bhatt, Gunvant. Tarsi vadli sukun gagan. Bombay: Lokpriya, 1991.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
10

Mūriyānah-ʼi tars. Tihrān: Intishārāt-i Tūs, 2000.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
More sources

Book chapters on the topic "TARS2"

1

Villars, P., K. Cenzual, J. Daams, R. Gladyshevskii, O. Shcherban, V. Dubenskyy, N. Melnichenko-Koblyuk, et al. "TaS2." In Landolt-Börnstein - Group III Condensed Matter, 691. Berlin, Heidelberg: Springer Berlin Heidelberg, 2008. http://dx.doi.org/10.1007/978-3-540-44752-8_579.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

O’Hara, James E., Igor UsUpensky, N. J. Bostanian, John L. Capinera, Reg Chapman, Carl S. Barfield, Marilyn E. Swisher, et al. "Tarsus (pl., Tarsi)." In Encyclopedia of Entomology, 3701. Dordrecht: Springer Netherlands, 2008. http://dx.doi.org/10.1007/978-1-4020-6359-6_2364.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Regnauld, Bernard. "Sinus Tarsi Syndrome." In The Foot, 498–500. Berlin, Heidelberg: Springer Berlin Heidelberg, 1986. http://dx.doi.org/10.1007/978-3-642-61605-1_34.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Ratliff, A. H. C., J. H. Dixon, P. A. Magnussen, and S. K. Young. "Tarso-Metatarsal Injuries." In Selected References in Orthopaedic Trauma, 111–12. London: Springer London, 1989. http://dx.doi.org/10.1007/978-1-4471-1695-0_74.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Dijkstra, Jelske, and Liesbeth Schlichting. "11 Frisian TARSP. Based on the Methodology of Dutch TARSP." In Assessing Grammar, edited by Martin J. Ball, David Crystal, and Paul Fletcher, 189–207. Bristol, Blue Ridge Summit: Multilingual Matters, 2012. http://dx.doi.org/10.21832/9781847696397-013.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Hempfling, H. "Das Sinus tarsi-Syndrom." In Fuß und oberes Sprunggelenk, 108–15. Heidelberg: Steinkopff, 2004. http://dx.doi.org/10.1007/978-3-7985-1940-4_15.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Dellon, A. Lee. "Lateral Ankle (Sinus Tarsi) Denervation." In Joint Denervation, 191–203. Cham: Springer International Publishing, 2019. http://dx.doi.org/10.1007/978-3-030-05538-7_11.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Ganal, P., W. Olberding, T. Butz, and G. Ouvrard. "Intercalation of Mercury into 1T-TaS2 and 2H-TaS2: A Combined TDPAC and X-Ray Study." In Chemical Physics of Intercalation II, 383–86. Boston, MA: Springer US, 1993. http://dx.doi.org/10.1007/978-1-4615-2850-0_44.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Revelli, J. F., and F. J. Disalvo. "Tantalum Disulfide (Tas2) and its Intercalation Compounds." In Inorganic Syntheses, 35–49. Hoboken, NJ, USA: John Wiley & Sons, Inc., 2007. http://dx.doi.org/10.1002/9780470132500.ch8.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Revelli, J. F., and F. J. Disalvo. "Tantalum Disulfide (TaS2 ) and Its Intercalation Compounds." In Inorganic Syntheses, 155–69. Hoboken, NJ, USA: John Wiley & Sons, Inc., 2007. http://dx.doi.org/10.1002/9780470132616.ch32.

Full text
APA, Harvard, Vancouver, ISO, and other styles

Conference papers on the topic "TARS2"

1

Prabhu, D., ArnabGoswami, Senthil Murugan Nagarajan, and M. Ananthi. "TARS- AI based PersonalAssistant." In 2021 4th International Conference on Computing and Communications Technologies (ICCCT). IEEE, 2021. http://dx.doi.org/10.1109/iccct53315.2021.9711890.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Khlibyshyn, Yuriy, Iryna Pochapska, Oleg Grynyshyn, and Oleh Hladkyi. "Preparation of bitumen using acidic tars." In Chemical technology and engineering. Lviv Polytechnic National University, 2019. http://dx.doi.org/10.23939/cte2019.01.394.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Sekas, John, and Adam van Staveren. "TARS w/TGP Testing and Certification." In 2005 U.S. Air Force T&E Days. Reston, Virigina: American Institute of Aeronautics and Astronautics, 2005. http://dx.doi.org/10.2514/6.2005-7653.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Landric, C., C. Alande, and M. Ndiaye. "Apport de la greffe gingivale épithélio conjonctive dans la reconstruction palpébrale." In 66ème Congrès de la SFCO. Les Ulis, France: EDP Sciences, 2020. http://dx.doi.org/10.1051/sfco/20206602014.

Full text
Abstract:
La reconstruction palpébrale fonctionnelle et esthétique implique une réhabilitation de tous les plans palpébraux. Elle se base sur la distinction de deux entités fonctionnelles: la lamelle postérieure qui comporte le tarse, la conjonctive et les rétracteurs qui assurent l’abaissement de la paupière dans le regard vers le bas; la lamelle antérieure cutanéo- musculaire qui assure l’occlusion palpébrale. Toute technique doit impérativement restaurer les deux lamelles fonctionnelles. La réhabilitation du plan postérieur tarsoconjonctival peut utiliser différents greffons autologues: identiques (greffes et lambeaux tarsoconjonctival), soit analogues (greffes cartilagineuses, chondro muqueuses ou fibro muqueuses). Le recouvrement cutané dépend lui de la situation de la perte de substance et de la paupière concernée. L’utilisation de la fibromuqueuse palatine en chirurgie palpébrale fut décrite pour la première fois par Siegel en 1985. Histologiquement, le greffon palatin comporte trois couches de la superficie à la profondeur : la couche muqueuse, épithélium malpighien kératinisé, la couche glandulaire sous-muqueuse et le périoste. Cette technique à trouvée son application au centre hospitalier de Pau, dans la reconstruction de la paupière inférieure d’une patiente, après exérèse carcinologique d’un carcinome basocellulaire du bord libre. Egalement dans la reconstruction d’un plan tarso conjonctival chez un patient enophtalme pour permettre un soutien de la prothèse oculaire. Ces chirurgies sont réalisées en doubles équipes afin de mutualiser les compétences. La fibromuqueuse palatine trouve une indication de choix dans la reconstruction de tout ou partie de la lamelle postérieure de la paupière inférieure. Elle est indiquée en seconde intention pour la paupière supérieure car le taux de complications semble y être plus élevé (Leibovitch 2006). Il est nécessaire de prélever un greffon 10% plus large que la taille du défect muqueux car la greffe palatine se rétracte légèrement à moyen terme (Hatoko 1999). La fibromuqueuse palatine offre de nombreux avantages : une incurvation adéquate « moulant » le globe oculaire, une rigidité satisfaisante, une excellente survie en association à un lambeau et une morbidité acceptable au niveau du site donneur. Cohen et Shorr ont également montré que la muqueuse palatine subit une métaplasie en épithélium non kératinisé limitant ainsi à terme les risques d’irritation cornéenne et de kératite. Par opposition aux greffes tarso conjonctivales, l’intérêt majeur est la préservation de la paupière antagoniste. Les inconvénients sont surtout liés aux complications possibles: un saignement palatin souvent précoce dans les 48h postopératoires (10% des cas) (Wearne 2001); un retard de cicatrisation; une infection palpébrale à Candida; une sécrétion salivaire palpébrale due à la persistance de glandes salivaires dans le greffon et qui peut être tarie par cryothérapie.
APA, Harvard, Vancouver, ISO, and other styles
5

Li, Weijian, and Gururaj V. Naik. "1T-TaS2 based dynamically tunable plasmonic metasurface." In CLEO: QELS_Fundamental Science. Washington, D.C.: Optica Publishing Group, 2022. http://dx.doi.org/10.1364/cleo_qels.2022.fth2d.3.

Full text
Abstract:
We demonstrate a dynamically tunable plasmonic metasurface enabled by light-tunable optical constants of a quantum material - 1T-TaS2. We observe a relative reflectance change of 10% under low-intensity incoherent illumination.
APA, Harvard, Vancouver, ISO, and other styles
6

Harimohan, V., A. Bharathi, R. Rajaraman, and C. S. Sundar. "A magneto-resistance and magnetisation study of TaAs2 semimetal." In DAE SOLID STATE PHYSICS SYMPOSIUM 2017. Author(s), 2018. http://dx.doi.org/10.1063/1.5029002.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Fourcault, Alice, Fre´de´ric Marias, and Ulysse Michon. "Design of a High Temperature Chamber FED by a Plasma Torch for Thermal Removal of Tars." In 17th Annual North American Waste-to-Energy Conference. ASMEDC, 2009. http://dx.doi.org/10.1115/nawtec17-2315.

Full text
Abstract:
Biomass is one of the most important sources of renewable energy. One aim of Biomass gasification is to convert a solid feedstock into a valuable syngas for electricity or liquid fuel production. Actual industrial auto-thermal gasification processes achieve a production of syngas mainly polluted by products such as dust, nitrogen oxides, sulfur dioxide and tars. Tars remain, one of the main drawbacks in using the gasification process since they are capable of condensing at low temperature. This could lead to fouling, corrosion, attrition and abrasion of downstream devices such as gas turbines or engines. Tars are often removed from the syngas, decreasing the internal energy of the syngas itself. These tars are heavy aromatic hydrocarbons whose treatment remains difficult by thermal, catalytic or even physical methods. They can condense or polymerize into more complex structures, and the mechanisms responsible for their degradation are not completely identified and understood. Turboplasma© is a thermal process, proposed by Europlasma. The main principle of operation relies on the use of thermal plasma for the cracking of tars inside a syngas produced in an auto-thermal gasification step. Basically, it consists of a degradation chamber where the syngas is heated by a plasma torch. The plasma plume provides a high temperature gas (around 5000K) to the system and enables heating of the incoming stream (above 1300K) and also generates high temperature zones (above 1600 K) inside the device. Due to both high temperature and long residence times of the syngas in the vessel, cracking of the tars occurs. Finally, the species released are mainly CO and H2, leading to an increase in the Lower Heating Value of the syngas. The work presented here describes the design of a high temperature gasification system assisted by thermal plasma. It was performed using a CFD computation implemented with a full chemical model for the thermal degradation of tars. The objectives were to understand the aerodynamic behavior of the vessel and to propose enhancement in its design. We present here some results of this study.
APA, Harvard, Vancouver, ISO, and other styles
8

Enomoto, Hiroyuki, Masayuki Kawaguchi, and Michael M. Lerner. "Syntheses and characterizations of polymer/TaS2 layered nanocomposites." In Optical Science and Technology, SPIE's 48th Annual Meeting, edited by Tianquan Lian and Hai-Lung Dai. SPIE, 2003. http://dx.doi.org/10.1117/12.504324.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Sharma, Rohit, Suman Karmakar, and R. Rawat. "Study of magnetoresistance in polycrystalline Fe intercalated TaS2." In 3RD INTERNATIONAL CONFERENCE ON CONDENSED MATTER AND APPLIED PHYSICS (ICC-2019). AIP Publishing, 2020. http://dx.doi.org/10.1063/5.0001191.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Vogt, V., and A. Weber. "Frakturversorgung von Calcaneusfrakturen über den minimal-invasiven Sinus Tarsi Zugang." In Deutscher Kongress für Orthopädie und Unfallchirurgie. Georg Thieme Verlag KG, 2020. http://dx.doi.org/10.1055/s-0040-1717409.

Full text
APA, Harvard, Vancouver, ISO, and other styles

Reports on the topic "TARS2"

1

Milne, T. A., R. J. Evans, and N. Abatzaglou. Biomass Gasifier ''Tars'': Their Nature, Formation, and Conversion. Office of Scientific and Technical Information (OSTI), November 1998. http://dx.doi.org/10.2172/3726.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Carpenter, D., M. Ratcliff, and D. Dayton. Catalytic Steam Reforming of Gasifier Tars: On-Line Monitoring of Tars with a Transportable Molecular-Beam Mass Spectrometer; Milestone Completion Report. Office of Scientific and Technical Information (OSTI), May 2002. http://dx.doi.org/10.2172/15000383.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Felix, Larry G. Engineering New Catalysts for In-Process Elimination of Tars. Office of Scientific and Technical Information (OSTI), September 2012. http://dx.doi.org/10.2172/1061282.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Suuberg, E. M. Vapor pressures and heats of vaporization of primary coal tars. Office of Scientific and Technical Information (OSTI), January 1992. http://dx.doi.org/10.2172/6562518.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Eric M. Suuberg and Vahur Oja. VAPOR PRESSURES AND HEATS OF VAPORIZATION OF PRIMARY COAL TARS. Office of Scientific and Technical Information (OSTI), July 1997. http://dx.doi.org/10.2172/774960.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Hayes, Monica. Retention Behavior of Enlisted TARs (Training and Administration of the Reserves) in Surface-Expansion Ratings. Fort Belvoir, VA: Defense Technical Information Center, December 1987. http://dx.doi.org/10.21236/ada197030.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Hatcher, H. J. Basic mechanisms in the biochemical modification of tars, heavy oils, and kerogen: FY-1988 progress report. Office of Scientific and Technical Information (OSTI), November 1988. http://dx.doi.org/10.2172/6350803.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Pradeep Agrawal. Stability and Regeneration of Catalysts for the Destruction of Tars from Bio-mass Black Liquor Gasification. Office of Scientific and Technical Information (OSTI), September 2004. http://dx.doi.org/10.2172/829966.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Suuberg, E. M. Vapor pressures and heats of vaporization of primary coal tars. Quarterly technical progress report, April 1--June 30, 1995. Office of Scientific and Technical Information (OSTI), October 1995. http://dx.doi.org/10.2172/113884.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Suuberg, E. M., V. Oja, and W. D. Lilly. Vapor pressures and heats of vaporization of primary coal tars. Quarterly technical progress report, July 1 - September 31, 1996. Office of Scientific and Technical Information (OSTI), December 1996. http://dx.doi.org/10.2172/468453.

Full text
APA, Harvard, Vancouver, ISO, and other styles
You might also be interested in the extended bibliographies on the topic 'TARS2' for particular source types:
Journal articles Dissertations / Theses Books
We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!

To the bibliography